The Chemours Company (NYSE:CC) Receives $22.40 Average Price Target from Brokerages

Posted by Stanley Muller on May 18th, 2026

The Chemours Company (NYSE:CC – Get Free Report) has been assigned a consensus rating of “Hold” from the thirteen brokerages that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, six have given a hold recommendation and six have assigned a buy recommendation to the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $23.0909.

CC has been the topic of several analyst reports. Morgan Stanley upped their price target on Chemours from $17.00 to $21.00 and gave the company an “equal weight” rating in a research report on Monday, May 11th. Mizuho set a $30.00 price target on Chemours in a research report on Wednesday, May 6th. JPMorgan Chase & Co. upped their price target on Chemours from $13.00 to $17.00 and gave the company a “neutral” rating in a research report on Monday, February 23rd. Royal Bank Of Canada upped their price target on Chemours from $26.00 to $29.00 and gave the company an “outperform” rating in a research report on Monday, May 11th. Finally, Truist Financial upped their price target on Chemours from $27.00 to $30.00 and gave the company a “buy” rating in a research report on Tuesday, April 28th.

View Our Latest Research Report on CC

Chemours Trading Up 0.1%

Shares of Chemours stock opened at $23.15 on Wednesday. Chemours has a 52-week low of $9.13 and a 52-week high of $28.67. The stock’s 50-day simple moving average is $21.96 and its 200 day simple moving average is $17.07. The stock has a market capitalization of $3.48 billion, a P/E ratio of -8.77 and a beta of 1.47. The company has a debt-to-equity ratio of 18.98, a quick ratio of 0.87 and a current ratio of 1.82.

Chemours (NYSE:CC – Get Free Report) last announced its quarterly earnings data on Tuesday, May 5th. The specialty chemicals company reported $0.05 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.10. Chemours had a positive return on equity of 52.49% and a negative net margin of 6.82%.The business had revenue of $1.38 billion for the quarter, compared to analysts’ expectations of $1.40 billion. During the same period in the previous year, the business posted $0.13 EPS. The firm’s quarterly revenue was up 1.0% compared to the same quarter last year. As a group, research analysts anticipate that Chemours will post 1.31 EPS for the current year.

Chemours Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 16th. Stockholders of record on Sunday, May 17th will be given a dividend of $0.0875 per share. The ex-dividend date is Friday, May 15th. This represents a $0.35 annualized dividend and a dividend yield of 1.5%. Chemours’s dividend payout ratio is currently -13.26%.

Institutional Investors Weigh In On Chemours

Hedge funds and other institutional investors have recently modified their holdings of the stock. Atlas Capital Advisors Inc. bought a new stake in shares of Chemours during the fourth quarter valued at about $26,000. Aster Capital Management DIFC Ltd bought a new position in shares of Chemours in the fourth quarter worth approximately $28,000. Covestor Ltd increased its position in shares of Chemours by 204.7% in the fourth quarter. Covestor Ltd now owns 2,602 shares of the specialty chemicals company’s stock worth $31,000 after purchasing an additional 1,748 shares during the last quarter. Eurizon Capital SGR S.p.A. bought a new position in shares of Chemours in the fourth quarter worth approximately $31,000. Finally, Rothschild Investment LLC increased its position in shares of Chemours by 87.0% in the fourth quarter. Rothschild Investment LLC now owns 2,698 shares of the specialty chemicals company’s stock worth $32,000 after purchasing an additional 1,255 shares during the last quarter. 76.26% of the stock is currently owned by institutional investors.

About Chemours

(Get Free Report)

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.